As we look to 2026, the story becomes one of defining firsts: the debut of oral GLP-1s, the first loss of exclusivity for a GLP-1 receptor antagonist, and landmark coverage decisions such as obesity medications entering Medicare formularies for obesity as a standalone indication
Normally, this is the last set of clinical trials before a medication can be licensed
Oral and injectable routes exist, each with distinct absorption profiles and clinical considerations
BACE1 cleaves APP to generate A
Both melanogenesis and anti-inflammatory signalling downstream of MC1R activation share the same upstream cAMP-PKA pathway
RetzlerRx uses Emothion , a patented ingredient from Gnosis Biotech , because its one of the most respected branded forms in this categoryknown for quality standards and consistency